ATE330620T1 - Verwendung von midkin oder von anti-midkin antikörper - Google Patents
Verwendung von midkin oder von anti-midkin antikörperInfo
- Publication number
- ATE330620T1 ATE330620T1 AT98931102T AT98931102T ATE330620T1 AT E330620 T1 ATE330620 T1 AT E330620T1 AT 98931102 T AT98931102 T AT 98931102T AT 98931102 T AT98931102 T AT 98931102T AT E330620 T1 ATE330620 T1 AT E330620T1
- Authority
- AT
- Austria
- Prior art keywords
- midkin
- antibodies
- midkine
- inducible
- heparin
- Prior art date
Links
- 102100030335 Midkine Human genes 0.000 abstract 2
- 108010092801 Midkine Proteins 0.000 abstract 2
- 102100031000 Hepatoma-derived growth factor Human genes 0.000 abstract 1
- 101001083798 Homo sapiens Hepatoma-derived growth factor Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000005012 migration Effects 0.000 abstract 1
- 238000013508 migration Methods 0.000 abstract 1
- 230000003448 neutrophilic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20532097 | 1997-07-14 | ||
| JP20533297 | 1997-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE330620T1 true ATE330620T1 (de) | 2006-07-15 |
Family
ID=26515003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98931102T ATE330620T1 (de) | 1997-07-14 | 1998-07-14 | Verwendung von midkin oder von anti-midkin antikörper |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7390491B2 (de) |
| EP (1) | EP0998941B9 (de) |
| JP (1) | JP2010215673A (de) |
| KR (1) | KR100571010B1 (de) |
| CN (1) | CN1287852C (de) |
| AT (1) | ATE330620T1 (de) |
| AU (1) | AU756279B2 (de) |
| CA (1) | CA2296409C (de) |
| DE (1) | DE69835016T2 (de) |
| WO (1) | WO1999003493A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002512200A (ja) * | 1998-04-17 | 2002-04-23 | アンジオジェニックス, インコーポレイテッド | 治療的な脈管形成因子およびその使用方法 |
| CN1222296C (zh) * | 1998-08-24 | 2005-10-12 | 村松乔 | 动脉硬化和ptca术后再狭窄的预防剂/治疗剂 |
| US20060259026A1 (en) * | 2005-05-05 | 2006-11-16 | Baylis Medical Company Inc. | Electrosurgical treatment method and device |
| US8221758B2 (en) | 2003-03-06 | 2012-07-17 | Cellmid Limited | Anti-midkine antibody for preventing post-laparotomy adhesions |
| JP4646070B2 (ja) * | 2003-03-27 | 2011-03-09 | メディカル セラピーズ リミテッド | 関節炎関連遺伝子及びこれの関節炎検査等への利用 |
| WO2007055378A1 (ja) * | 2005-11-14 | 2007-05-18 | Cell Signals Inc. | 調節性t細胞の機能異常に基づく疾患の治療方法及び予防方法 |
| ES2397715T3 (es) | 2006-11-14 | 2013-03-08 | Ribomic Inc | Aptámero contra midkina y uso del mismo |
| US9163081B2 (en) | 2006-11-14 | 2015-10-20 | Medical Therapies Limited | Antibody recognizing C-domain of midkine |
| WO2010074218A1 (ja) * | 2008-12-25 | 2010-07-01 | 株式会社イーベック | 抗ヒトミッドカイン抗体 |
| US20110212181A1 (en) * | 2010-02-26 | 2011-09-01 | The University Of Hong Kong | Compositions and methods for treating chronic respiratory inflammation |
| WO2012122590A1 (en) | 2011-03-14 | 2012-09-20 | Cellmid Limited | Antibody recognizing n-domain of midkine |
| AU2013297478B2 (en) | 2012-07-30 | 2018-12-20 | Medical & Biological Laboratories Co., Ltd. | Monoclonal antibody against human midkine |
| KR101985300B1 (ko) * | 2016-07-19 | 2019-06-03 | 삼성전자주식회사 | 미드카인 저해제를 포함하는 뇌종양 치료 또는 예방용 약학 조성물 |
| CN118304417B (zh) | 2024-06-11 | 2024-08-09 | 四川大学华西医院 | 一种能够抑制mdk表达的物质在制备治疗ddh药物中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL79254A0 (en) * | 1986-06-26 | 1986-09-30 | Hadassah Med Org | Compositions for preventing graft rejection |
| US5206223A (en) * | 1986-06-26 | 1993-04-27 | Yeda Research And Development Co. Ltd. | Method for inhibiting heparanase activity |
| US5210026A (en) * | 1990-08-20 | 1993-05-11 | American Cyanamid Company | Human mk gene and method of expression |
| EP0583360B1 (de) | 1991-05-02 | 2002-05-22 | Yeda Research And Development Co. Ltd. | Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessen |
| EP0535336A3 (en) * | 1991-09-30 | 1993-05-19 | American Cyanamid Company | Mk protein as cell growth inhibitor |
| US5461029A (en) * | 1992-04-24 | 1995-10-24 | American Cyanamid Company | Method of treating herpes viral infections using HBNF and MK proteins |
| AU7205894A (en) * | 1993-06-08 | 1995-01-03 | Neogenix, Inc. | Purified natural and synthetic compounds for the treatment of osteoarthritis |
| DE69621528T2 (de) | 1995-02-07 | 2003-01-16 | Shiseido Co. Ltd., Tokio/Tokyo | Anti-inflamatorische agenzien |
| JPH08277224A (ja) * | 1995-02-07 | 1996-10-22 | Shiseido Co Ltd | 抗炎症剤 |
| US5629284A (en) * | 1995-07-24 | 1997-05-13 | Meiji Milk Products Co., Ltd. | Method for treating retinal diseases |
| JPH0995454A (ja) * | 1995-10-02 | 1997-04-08 | Meiji Milk Prod Co Ltd | 抗潰瘍組成物 |
| ATE299030T1 (de) * | 1996-07-10 | 2005-07-15 | Meiji Dairies Corp | Verwendung von proteinen aus der mk familie als hämatopoietischer faktor |
-
1998
- 1998-07-14 EP EP98931102A patent/EP0998941B9/de not_active Expired - Lifetime
- 1998-07-14 KR KR1020007000378A patent/KR100571010B1/ko not_active Expired - Fee Related
- 1998-07-14 CA CA2296409A patent/CA2296409C/en not_active Expired - Fee Related
- 1998-07-14 CN CNB988089343A patent/CN1287852C/zh not_active Expired - Fee Related
- 1998-07-14 WO PCT/JP1998/003161 patent/WO1999003493A1/ja not_active Ceased
- 1998-07-14 AT AT98931102T patent/ATE330620T1/de not_active IP Right Cessation
- 1998-07-14 AU AU81310/98A patent/AU756279B2/en not_active Ceased
- 1998-07-14 DE DE69835016T patent/DE69835016T2/de not_active Expired - Lifetime
-
2002
- 2002-11-18 US US10/298,889 patent/US7390491B2/en not_active Expired - Fee Related
-
2010
- 2010-07-09 JP JP2010156986A patent/JP2010215673A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0998941A4 (de) | 2004-05-12 |
| WO1999003493A1 (en) | 1999-01-28 |
| CA2296409A1 (en) | 1999-01-28 |
| JP2010215673A (ja) | 2010-09-30 |
| CA2296409C (en) | 2010-05-18 |
| CN1287852C (zh) | 2006-12-06 |
| DE69835016T2 (de) | 2007-06-28 |
| EP0998941B1 (de) | 2006-06-21 |
| EP0998941B9 (de) | 2007-03-14 |
| KR20010021814A (ko) | 2001-03-15 |
| US7390491B2 (en) | 2008-06-24 |
| CN1306435A (zh) | 2001-08-01 |
| AU8131098A (en) | 1999-02-10 |
| US20030072739A1 (en) | 2003-04-17 |
| KR100571010B1 (ko) | 2006-04-13 |
| EP0998941A1 (de) | 2000-05-10 |
| AU756279B2 (en) | 2003-01-09 |
| DE69835016D1 (de) | 2006-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69835016D1 (de) | Verwendung von midkin oder von anti-midkin antikörper | |
| DE3667378D1 (de) | Verwendung von n-(4-phenoxy-2,6-diisopropylphenyl)-n'-tert.butylthioharnstoff zur bekaempfung von weissen fliegen. | |
| DE69008423D1 (de) | Dynamische Fixierung von Schweinsaortaklappen. | |
| EP0963197A4 (de) | Guanylhydrazone die nützlich sind zur behandlung von mit t-zellen verbundenen krankheiten | |
| ATE286510T1 (de) | In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper | |
| DE3687069D1 (de) | Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen. | |
| ATE245442T1 (de) | Getrocknete zubereitung von bluttfaktoren, enthaltend trehalose | |
| FI920992L (fi) | Foerfarande foer framstaellning av i industriell skala av ett standardiserat koncentrat av human von willebrand-faktor, vilket har synnerligen hoeg renhet och aer laempligt foer terapeutisk anvaendning | |
| DK0654078T3 (da) | Thrombinblodfraktion til anvendelse i en medicinsk procedure | |
| DE3788984D1 (de) | Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom. | |
| DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
| ATE103932T1 (de) | Fusionsprotein bestehend aus gm-csf und il-3. | |
| DE69001839D1 (de) | 1-hydroxyvitamin d2-epimer und dessen derivate. | |
| DE3774858D1 (de) | Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeuren und deren verwendung als collagenase-inhibitoren. | |
| DE3680000D1 (de) | Stabilisierte aktive formen von vitamin-d3. | |
| EP0209543A4 (de) | Peptidfragmente menschlicher apolipoproteine, typspezifische antikörper und verwendungsverfahren. | |
| DE69531048D1 (de) | Verwendung von steroidsulphatase-hemmern | |
| ATE208042T1 (de) | Hapten-analoge zur verwendung in immunoassays | |
| DE69319576D1 (de) | Verwendung von Furanonen wie Duftstoffe | |
| DE69414194D1 (de) | Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren | |
| ATE227557T1 (de) | Verwendung von zahnpflegemitteln enthaltend bovines kolostrum | |
| ATE222896T1 (de) | Substituierte thiazoline und ihre verwendung zur bekämpfung von tierischen schädlingen | |
| ATE493951T1 (de) | Kortikalknochenimplantat für wirbelfusion nach smith-robinson | |
| DE3751362D1 (de) | 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva. | |
| DE3871712D1 (de) | Suspensionen und verwendung dieser suspensionen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |